A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

NCT01298505 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Stopped This study was stopped due to lack of evidence for clinical efficacy.

Conditions

Healthy

Interventions

DRUG: PF-03654764 2.5mg plus fexofenadine 60mg
DRUG: PF-03654764 5mg plus fexofenadine 60mg
DRUG: placebo

Sponsor

Pfizer